Drug of Choice for Allergic Cough
For allergic cough specifically due to allergic rhinitis, nasal corticosteroids, oral antihistamines, and/or nasal cromolyn are the initial drug choices, with nasal corticosteroids and second-generation (nonsedating) antihistamines being preferred first-line agents. 1
First-Line Treatment Options
Nasal Corticosteroids (Preferred)
- Nasal corticosteroids are among the initial drug choices for allergic rhinitis-induced cough and have been shown to effectively reduce both nasal inflammation and associated cough symptoms 1
- Mometasone furoate nasal spray significantly improved daytime cough severity scores (P = 0.049) and overall daytime symptom scores (P = 0.005) in patients with seasonal allergic rhinitis-associated cough 2
- These agents work by reducing nasal inflammation that triggers the upper airway cough reflex 2
Second-Generation (Nonsedating) Antihistamines
- Nonsedating antihistamines (loratadine, desloratadine, cetirizine, fexofenadine) are likely to be more effective in treating allergic rhinitis-associated cough than in nonallergic rhinitis 1
- These agents are preferred over first-generation antihistamines because they produce less sedation and impairment while maintaining efficacy 3
- Loratadine 10 mg daily significantly reduced cough frequency (P < 0.05) and cough intensity (P < 0.01) in patients with allergic rhinoconjunctivitis and cough 4
Nasal Cromolyn
- Nasal cromolyn is listed as one of the initial drug choices for allergic rhinitis-induced cough based on controlled studies 1
Alternative and Adjunctive Options
Oral Leukotriene Inhibitors
- Leukotriene blockers (such as montelukast) have been shown to decrease symptoms of allergic rhinitis and may be considered as an alternative or adjunctive therapy 1
- Montelukast works by blocking the CysLT1 receptor, inhibiting the physiologic actions of leukotriene D4 5
First-Generation Antihistamines Plus Decongestant
- First-generation antihistamines combined with decongestants are NOT the preferred choice for allergic rhinitis-associated cough because the anticholinergic effect that makes them useful in nonallergic rhinitis is less relevant when histamine is the primary mediator 1
- However, combinations like dexbrompheniramine 6 mg bid or azatadine 1 mg bid plus pseudoephedrine 120 mg bid may be considered if second-generation agents fail 1
Treatment Algorithm for Allergic Cough
Confirm allergic etiology: Positive skin test to allergens, seasonal or perennial pattern, associated rhinitis symptoms 1
Initiate first-line therapy with either:
Assess response within days to 2 weeks 1
If inadequate response, consider:
If still inadequate, consider first-generation antihistamine/decongestant combination 1
Critical Pitfalls to Avoid
- Do not use first-generation antihistamines as first-line for allergic cough – they cause sedation, impairment, and worsen sleep architecture without offering superior efficacy for histamine-mediated conditions 3
- Avoid topical decongestants for prolonged use – use only short-term to prevent rebound congestion and rhinitis medicamentosa 6
- Do not use newer-generation antihistamines like terfenadine or loratadine plus pseudoephedrine for postviral cough – these have been shown ineffective for non-histamine-mediated cough 1
- Recognize that cough persisting beyond 3 weeks requires full diagnostic workup rather than continued empiric treatment 7
- Consider that allergic rhinitis itself may cause sedation and impairment, so using sedating antihistamines compounds this problem 3
Special Considerations
- For nocturnal cough disrupting sleep, first-generation sedating antihistamines may be appropriate due to their sedative properties 7, 8
- Allergen avoidance is always desirable but usually not completely possible 1
- Most patients show improvement within days to 2 weeks of initiating appropriate therapy 1
- Second-generation antihistamines are preferred for all patients, particularly those at higher risk for adverse effects from sedation (drivers, machinery operators, students) 3